FDA on Medscape

This collection features FDA experts in original commentaries that are designed to improve communications between clinicians and this important federal agency. It covers a wide range of topics related to FDA's multi-faceted mission of protecting and promoting the public health by ensuring the safety and quality of medical products such as drugs, foods, and medical devices.

Latest from FDA

FDA's Commitment to COVID Testing 2020 presented challenges but also significant achievements, write FDA officials.
FDA Expert Commentaries and Interviews, January 19, 2021
FDA Updates Regulations on Mammography Proposed amendments to mammography regulations include increased reporting to patients and providers and greater transparency about mammography facilities.
FDA Expert Commentaries and Interviews, June 14, 2019
Vaping and e-Cigarettes in Kids: An Unprecedented Epidemic We are at the start of a rise in youth use of vaping products that is unprecedented in scope and exceeds growth rates previously seen with any other products. Clinicians have to be part of the response team.
FDA Expert Commentaries and Interviews, January 28, 2019
Drug Safety Warnings and Updates: April-June 2018 Don't miss these important summaries of safety labeling changes and boxed warnings by the FDA for the second quarter of 2018.
FDA Expert Commentaries and Interviews, September 10, 2018
Recommendations to Reduce Surgical Fires and Patient Injury Dr Lila Bahadori discusses the FDA's recent safety communication reviewing the factors that contribute to surgical fires and recommending practices to reduce them.
FDA Expert Commentaries and Interviews, May 29, 2018
Drug Safety Warnings and Updates: January-March 2018 Don't miss these important summaries of safety labeling changes and boxed warnings by the FDA for the first quarter of 2018.
FDA Expert Commentaries and Interviews, May 23, 2018
Drugs With a REMS: Benefit/Risk Counseling to Patients Do you know what to do when counseling a patient on a drug with a REMS designation? Learn more with new guidance from the FDA.
FDA Expert Commentaries and Interviews, February 20, 2018
Drug Safety Warnings and Updates: October-December 2017 Don't miss these important summaries of safety labeling changes and boxed warnings by the FDA for the fourth quarter of 2017.
FDA Expert Commentaries and Interviews, February 16, 2018
Safety in Pediatric Imaging: FDA Releases New Guidance When it comes to pediatric imaging, new guidance from the FDA offers specific recommendations for both practicing clinicians and equipment manufacturers.
FDA Expert Commentaries and Interviews, January 5, 2018
Drug Safety Warnings and Updates: July-September 2017 Don't miss these important summaries of safety labeling changes and boxed warnings by the FDA for the third quarter of 2017.
FDA Expert Commentaries and Interviews, January 3, 2018

FDA Mission

FDA is responsible for protecting the public health by assuring the safety, efficacy and security of human and veterinary drugs, biological products, medical devices, our nation's food supply, cosmetics, and products that emit radiation.

FDA is also responsible for advancing the public health by helping to speed innovations that make medicines more effective, safer, and more affordable and by helping the public get the accurate, science-based information they need to use medicines and foods to maintain and improve their health. FDA also has responsibility for regulating the manufacturing, marketing and distribution of tobacco products to protect the public health and to reduce tobacco use by minors.

Finally, FDA plays a significant role in the Nation's counterterrorism capability. FDA fulfills this responsibility by ensuring the security of the food supply and by fostering development of medical products to respond to deliberate and naturally emerging public health threats.

Latest from FDA

FDA Mission

FDA Resources